Correlation Between Norman Broadbent and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both Norman Broadbent and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Norman Broadbent and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Norman Broadbent Plc and Mereo BioPharma Group, you can compare the effects of market volatilities on Norman Broadbent and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Norman Broadbent with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Norman Broadbent and Mereo BioPharma.

Diversification Opportunities for Norman Broadbent and Mereo BioPharma

0.71

Correlation Coefficient

Norman Broadbent  Mereo BioPharma

Poor diversification

The 3 months correlation between Norman and Mereo is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Norman Broadbent Plc and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Norman Broadbent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Norman Broadbent Plc are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Norman Broadbent i.e., Norman Broadbent and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Norman Broadbent and Mereo BioPharma

Assuming the 90 days trading horizon Norman Broadbent Plc is expected to under-perform the Mereo BioPharma. In addition to that, Norman Broadbent is 1.01 times more volatile than Mereo BioPharma Group. It trades about -0.16 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.04 per unit of volatility. If you would invest  446.00  in Mereo BioPharma Group on September 12, 2024 and sell it today you would lose (60.00) from holding Mereo BioPharma Group or give up 13.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Norman Broadbent Plc  vs.  Mereo BioPharma Group

Norman Broadbent Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Norman Broadbent Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Norman Broadbent and Mereo BioPharma

The main advantage of trading using opposite Norman Broadbent and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Norman Broadbent position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind Norman Broadbent Plc and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.